Ghent University Academic Bibliography

Journal Article
A1
open access

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Philipp Heumann, Miguel E. Aguado-Barrera, Barbara Avuzzi, David Azria, Erik Briers, Renée Bultijnck (UGent) , Ananya Choudhury, Dirk De Ruysscher, Marie-Pierre Farcy-Jacquet, Valerie Fonteyne (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 178.

Add to list

Journal Article
open access

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study

Lotte van der Weijst (UGent) , David Azria, PATRICK BERKOVIC (UGent) , Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, et al.

(2022) Radiotherapy and Oncology. 176. p.127-137

Add to list

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

T. Zilli, S. Siva, R. Heikkila, P. Dirix, N. Liefhooghe, F. Otte, A. Gomez-Iturriaga, W. Everaerts, M. Shelan, A. Conde-Moreno, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 170(S1). p.S528-S529

Add to list

ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium

Florian Charlier, Thomas Descamps, Yolande Lievens (UGent) , Xavier Geets, Vincent Remouchamps, Maarten Lambrecht and Luigi Moretti

(2022) RADIOTHERAPY AND ONCOLOGY. 167. p.57-64

Add to list

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William Hall, Kim De Ruyck (UGent) , et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 168. p.75-82

Add to list

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Willeke Danckaert (UGent) , Mathieu Spaas (UGent) , Katrien Vandecasteele (UGent) , Carlos De Wagter (UGent) and Piet Ost (UGent)

(2022) RADIOTHERAPY AND ONCOLOGY. 170. p.64-69

Add to list

Journal Article
A1
open access

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Sofia C. Vaz, Judit A. Adam, Roberto C. Delgado Bolton, Pierre Vera, Wouter van Elmpt, Ken Herrmann, Rodney J. Hicks, Yolande Lievens (UGent) , Andrea Santos, Heiko Schöder, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 168. p.37-39

Add to list

Journal Article
A1
open access

Variable and fixed costs in NHS radiotherapy : consequences for increasing hypo fractionation

Katie Spencer, Noemie Defourny, David Tunstall, Viv Cosgrove, Karen Kirkby, Ann Henry, Yolande Lievens (UGent) and Peter Hall

(2022) RADIOTHERAPY AND ONCOLOGY. 166. p.180-188

Add to list

Journal Article
A1
open access

Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink

Josep M. Borras, Julieta Corral, Ajay Aggarwal, Riccardo Audisio, Josep Alfons Espinas, Josep Figueras, Peter Naredi, Dimitra Panteli, Nicolas Pourel, Joan Prades, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 169. p.114-123

Add to list

Journal Article
A1
open access

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

B.G. Wortman, E. Astreinidou, M.S. Laman, E.M. van der Steen-Banasik, L.C.H.W. Lutgens, H. Westerveld, F. Koppe, A. Slot, H.A. van den Berg, M.E. Nowee, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 155. p.160-166

Academic Bibliography

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Variable and fixed costs in NHS radiotherapy : consequences for increasing hypo fractionation

Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

Contents

Support

Contact